World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
11669
World Ranking
3264
National Ranking
1521

Susan W. Barnett publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Susan W. Barnett sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 219 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Susan W. Barnett D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Susan W. Barnett sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Susan W. Barnett is affiliated with the Bill & Melinda Gates Foundation in the United States. Their research primarily focuses on immunology and microbiology, with significant contributions to the fields of virology, molecular biology, epidemiology, immunology, and infectious diseases. The main topics covered in their work include HIV research and treatment, vaccines and immunoinformatics approaches, virology and viral diseases, Hepatitis B virus studies, HIV/AIDS drug development and treatment, monoclonal and polyclonal antibodies research, and immune responses and vaccinations.

Recent publications by Susan W. Barnett include:

  • "Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults", 2021, New England Journal of Medicine
  • "Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein", 2020, Clinical Infectious Diseases
  • "HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens", 2020, Scientific Reports
  • "Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type", 2020, PLoS Pathogens
  • "Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial", 2024, PLoS Medicine

Frequent co-authors collaborating with Barnett include:

  • Georgia D. Tomaras
  • Marguerite Koutsoukos
  • Olivier Van Der Meeren
  • M. Juliana McElrath
  • Lawrence Corey

The main publication venues for their work are:

  • New England Journal of Medicine
  • Clinical Infectious Diseases
  • Scientific Reports
  • PLoS Pathogens
  • PLoS Medicine

Best Publications

  • Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

    Georg Widera;Melissa Austin;Dietmar Rabussay;Cheryl Goldbeck

  • Nonviral delivery of self-amplifying RNA vaccines

    Andrew J. Geall;Ayush Verma;Gillis R. Otten;Christine A. Shaw

  • Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

    David J. M. Lewis;Zhiming Huo;Susan Barnett;Ingrid Kromann

  • A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

    Luis A Brito;Michelle Chan;Christine A Shaw;Armin Hekele

  • Enhancement of DNA vaccine potency in rhesus macaques by electroporation

    Gillis Otten;Mary Schaefer;Barbara Doe;Hong Liu

  • Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

    Indresh K. Srivastava;Leonidas Stamatatos;Elaine Kan;Michael Vajdy

  • Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.

    Derek O'Hagan;Manmohan Singh;Mildred Ugozzoli;Carl Wild

  • Adjuvant-dependent Innate and Adaptive Immune Signatures of Risk of SIVmac251 Acquisition

    Monica Vaccari;Shari N Gordon;Slim Fourati;Luca Schifanella;Luca Schifanella

  • Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.

    Frank Liang;Gustaf Lindgren;Kerrie J. Sandgren;Elizabeth A. Thompson

  • Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

    Glenda E. Gray;Glenda E. Gray;Glenda E. Gray;Linda Gail Bekker;Fatima Laher;Mookho Malahleha

  • Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

    Susan W. Barnett;Sabita Rajasekar;Harold Legg;Barbara Doe

  • Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 <i>gag</i> Gene

    Unknown

  • Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

    Victoria R. Polonis;Bruce K. Brown;Andrew Rosa Borges;Susan Zolla-Pazner

  • Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

    Willy M. Bogers;Herman Oostermeijer;Petra Mooij;Gerrit Koopman

  • Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.

    N. A. Doria-Rose;G. H. Learn;A. G. Rodrigo;D. C. Nickle

  • Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes

    Claudio Ciferri;Sumana Chandramouli;Danilo Donnarumma;Pavel A. Nikitin

  • Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

    Bo Peng;Liqun Rejean Wang;Victor Raúl Gómez-Román;Alberta Davis-Warren

  • Infection of Human Dendritic Cells by a Sindbis Virus Replicon Vector Is Determined by a Single Amino Acid Substitution in the E2 Glycoprotein

    Jason P. Gardner;Ilya Frolov;Silvia Perri;Yaying Ji

  • Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.

    Susan W Barnett;Indresh K Srivastava;Elaine Kan;Fengmin Zhou

  • Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus

    Indresh K. Srivastava;Leonidas Stamatatos;Harold Legg;Elaine Kan

  • The Human Immunodeficiency Viruses

    Edward Barker;Susan W. Barnett;Leonidas Stamatatos;Jay A. Levy

Frequent Co-Authors

David C. Montefiori
David C. Montefiori Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Jeffrey B. Ulmer
Jeffrey B. Ulmer Novartis (Switzerland)
Jonathan L. Heeney
Jonathan L. Heeney University of Cambridge
Guido Ferrari
Guido Ferrari Duke University
Leonidas Stamatatos
Leonidas Stamatatos Fred Hutchinson Cancer Research Center
Celia C. LaBranche
Celia C. LaBranche Duke University
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
David Venzon
David Venzon National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the field of Immunology, exploring related healthcare degrees can open up diverse career opportunities. Nursing plays a critical role in patient care and immunological research, making it a popular pathway. Students looking for quicker entry routes might consider the easiest accelerated nursing programs, which offer condensed timelines without compromising quality.

Another important option is Licensed Practical Nurse (LPN) programs. Finding accredited LPN programs easy to get into ensures faster access to the healthcare field with foundational skills applicable in immunology-related settings.

For advanced practice roles, pursuing nurse practitioner degrees is a beneficial step. One can explore easiest nurse practitioner degree programs to balance program accessibility with professional growth. Specialized fields, such as psychiatric-mental health, also intersect with immunological health, making the best pmhnp programs an important consideration for those aiming to enhance clinical skills with strong placement rates.

Overall, these related online programs provide pathways that complement immunology studies, advancing careers within healthcare and research sectors.

Best Scientists Citing Susan W. Barnett

Trending Scientists

Recently Published Articles